TopFunds

MetLife

NYSE: MET

Stock price

94 USD

(+Infinity%) NaN day

Life & Health InsuranceInsurance - Life

Financial Performance

Share

5Y price score: 87

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 196.1%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    67.3

    52-week range

    94.8

    94

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    26.4 %

    Dividend Yield TTM

    2.4 %

    Market cap $

    $ 60,483

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    18.2

    Price / Book TTM

    2.2

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    (0.9)

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    24.5 %

    81.2 %

    196.1 %

    Free cash flow per share growth

    28.1 %

    116.1 %

    130.2 %

    Earnings per share growth

    (19.2) %

    (15.5) %

    5 %

    Founded: 1,868

    Employees: 45,000

    Business Summary:MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    2026 Q1 (May 7, 2026)

    1) Strategy & Leadership
    - MetLife's Q1 2026 performance reflects the successful execution of the New Frontier strategy, focusing on diversified businesses and disciplined capital allocation.
    - The company aims to establish itself as a high-quality compounder over time, with Year 2 of the strategy emphasizing acceleration and execution across its market-leading businesses.
    - Leadership changes include the addition of Dan Glaser and Michelle Seitz to the Board of Directors, enhancing governance and expertise.

    2) Financial & Segment Results
    - Adjusted earnings reached $1.6 billion ($2.42 per share), an 18% increase YoY, with adjusted EPS growing 23%.
    - Adjusted premiums, fees, and other revenues (excluding pension risk transfers) rose 10% YoY, driven by broad-based growth across nearly all segments.
    - Key segment performances included:
    - Group Benefits: Adjusted earnings of $439 million (+19% YoY), with total sales up 15%.
    - Retirement & Income Solutions (RIS): Adjusted earnings of $451 million (+11% YoY), bolstered by strong variable investment income.
    - Asia: Adjusted earnings of $487 million (+31% YoY), with sales up 22% on a constant currency basis.
    - Latin America: Adjusted earnings of $229 million (+5% YoY), with sales increasing 20%.
    - EMEA: Adjusted earnings of $110 million (+33% YoY), with adjusted PFOs up 15% on a constant currency basis.
    - MetLife Investment Management (MIM): Adjusted earnings of $47 million (+68% YoY), despite a slight decline in institutional client assets under management.

    3) Problems / Headwinds
    - The company faced challenges with net investment losses due to trading activity within the fixed maturity portfolio.
    - There were modest net third-party outflows in MIM, attributed to market volatility and integration challenges post-PineBridge acquisition.
    - Regulatory scrutiny in Japan has raised concerns, although MetLife has not seen a direct impact on its business performance.

    4) Operational or Product Plans
    - MetLife continues to leverage artificial intelligence to enhance operational efficiency and customer service, with over $3.2 billion invested in technology modernization over the past five years.
    - The company is actively managing its investment portfolio, focusing on private assets and maintaining a high-quality, diversified approach.
    - Plans for the future include further integration of PineBridge and capitalizing on cross-selling opportunities in international markets.

    5) Guidance & Outlook / Investor Angle
    - MetLife expects to maintain strong performance with adjusted earnings guidance for RIS between $1.6 billion to $1.8 billion for the full year.
    - The company is committed to returning capital to shareholders, having repurchased approximately $750 million in shares and increased dividends by 4.4%.
    - Overall, MetLife's strong capital position, liquidity, and disciplined execution support a positive outlook for continued growth and shareholder value.

    Bottom line: MetLife's robust Q1 2026 results demonstrate the effectiveness of its New Frontier strategy, characterized by strong earnings growth, disciplined capital management, and a commitment to innovation. The company is well-positioned to navigate challenges and deliver sustainable value to shareholders.

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    MetLife — Financial Overview, Stock Price, Market Cap

    MetLife is a company. Founded in 1868. As of July 20, 2026, the company's market capitalization is $60483057226 with a current stock price of $94.00.